Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2004-08-23
2011-12-06
Spivack, Phyllis G. (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S615000, C514S617000
Reexamination Certificate
active
08071652
ABSTRACT:
A treatment to differentially regulate the expression of genes related to irritable bowel syndrome is provided.
REFERENCES:
patent: 4489710 (1984-12-01), Spitler
patent: 4554101 (1985-11-01), Hopp
patent: 4569789 (1986-02-01), Blattler et al.
patent: 4625014 (1986-11-01), Senter et al.
patent: 4638045 (1987-01-01), Kohn et al.
patent: 4671958 (1987-06-01), Rodwell et al.
patent: 4912094 (1990-03-01), Myers et al.
patent: 4980281 (1990-12-01), Housey
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5078996 (1992-01-01), Conlon, III et al.
patent: 5151254 (1992-09-01), Arai et al.
patent: 5266464 (1993-11-01), Housey
patent: 5459039 (1995-10-01), Modrich et al.
patent: 5498531 (1996-03-01), Jarrell
patent: 5688635 (1997-11-01), Parker et al.
patent: 5723127 (1998-03-01), Scott et al.
patent: 5817879 (1998-10-01), Hirschmann et al.
patent: 5877007 (1999-03-01), Housey
patent: 5919619 (1999-07-01), Tullis
patent: 5933819 (1999-08-01), Skolnick et al.
patent: 6207646 (2001-03-01), Krieg et al.
patent: 6420119 (2002-07-01), Polan et al.
patent: 6596747 (2003-07-01), Liu et al.
patent: 2002/0022637 (2002-02-01), Li et al.
patent: WO 92/19265 (1992-11-01), None
patent: WO 97/24447 (1997-07-01), None
patent: WO 99/14346 (1999-03-01), None
patent: WO 00/18434 (2000-04-01), None
patent: WO 01/29058 (2001-04-01), None
Borovikova, L., et al. “Role of Vagus Nerve Signaling in CNI-1493-Mediated Suppression of Acute Inflammation,” 2000, Autonomic Neuroscience: Basic and Clinical, vol. 85, pp. 141-147.
Al-chaer, E., et al., “A New Model of Chronic Visceral Hypersensitivity in Adult Rats Induced by Colon Irritation During Postnatal Development,” Gastroenterology, 2000 vol. 119, pp. 1276-1285.
Verdu, Elena, et al, “Irritable Bowel Syndrome,” Best Practice & Research Clinical Gastroenterology, vol. 18, No. 2, pp. 315-321 (2004).
The Merck Manual, 17thedition (1999), pp. 312-313.
Marlow, S., et al., “Deficient Innervation Characterizes Intestinal Strictures in a Rat Model of Colitis,” Experimental and Molecular Pathology, 80:54-66 (2006).
McKaig, B., et al., “Differential Expression of TGF-β Isoforms by Normal and Inflammatory Bowel Disease Intestinal Myofibroblasts,” Am J Physiol Cell Physiol, 282:C172-C182 (2002).
Pucilowska, J., et al., “IGF-I and Procollagen α1(I) are Coexpressed in a Subset of Mesenchymal Cells in Active Chron's Disease,” Am J. Physiol Gastrointest Liver Physiol, 279:G1307-G1322 (2000).
Pasricha Pankaj
Shenoy Mohan
Winston John
Adler Benjamin
Spivack Phyllis G.
The Board of Regents of the University of Texas System
LandOfFree
Method of treating irritable bowel syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating irritable bowel syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating irritable bowel syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4315915